HemoSonics, LLC is breaking new ground in point-of-care Viscoelastic #hemostasis testing. When time is critical, the Quantra® QPlus® System offers rapid, accurate, and easy to understand results that enable clinicians to make more informed #transfusion decisions, more quickly. This novel, cartridge-based POC VET system now has De Novo marketing authorization in the USA and is intended to assess the coagulation status of perioperative patients at the point of care.

Information Technology

HemoSonics

Robert A. Roda

Alexander Johnson

W. Sue Hamlett

MacKenzie Newton

Shaun Winnail

Joseph A. Steele

John Friedl

Mark C. Hennessy

Deborah O. Sinclair

Bruce D. Spiess

Deborah Winegar

Raymond L Szafranski Jr

Francesco Viola

Joe Steele

Thomas Givens

The Scientific and Development Team at HemoSonics is responsible for the research, development, optimization, and support of the company's innovative point-of-care viscoelastic hemostasis testing systems. This multidisciplinary team works collaboratively to develop assays, support technical operations, conduct clinical research, and manage reagent manufacturing, ensuring the delivery of rapid, accurate, and reliable coagulation status assessments to clinicians.

Scientific and Development Team

Clinical and Medical Team

Engineering Team

Scientific and Development Team

About

Team members

Other teams at HemoSonics

Clinical and Medical Team

Engineering Team